{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T15:23:14Z","timestamp":1785511394403,"version":"3.56.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","derm.theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.det.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,6,28]],"date-time":"2016-06-28T03:47:20Z","timestamp":1467085640000},"page":"291-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Practice and Educational Gaps in Abnormal Pigmentation"],"prefix":"10.1016","volume":"34","author":[{"given":"Tasneem F.","family":"Mohammad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltefat H.","family":"Hamzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.det.2016.02.005_bib1","first-page":"401","article-title":"Dyschromia in skin of color","volume":"13","author":"Kang","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.02.005_bib2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.fsc.2011.05.010","article-title":"Treatment of hyperpigmentation","volume":"19","author":"Rossi","year":"2011","journal-title":"Facial Plast Surg Clin North Am"},{"issue":"2","key":"10.1016\/j.det.2016.02.005_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.det.2013.12.008","article-title":"What's new in objective assessment and treatment of facial hyperpigmentation?","volume":"32","author":"Molinar","year":"2014","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.det.2016.02.005_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/ajd.12290","article-title":"Melasma: clinical diagnosis and management options","volume":"56","author":"Rodrigues","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.02.005_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jaad.2013.09.017","article-title":"Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris","volume":"70","author":"Savory","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2016.02.005_bib6","article-title":"An in\u00a0vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric, and clinical traits","author":"Isedeh","year":"2015","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2016.02.005_bib7","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","article-title":"The treatment of melasma: a review of clinical trials","volume":"55","author":"Gupta","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.det.2016.02.005_bib8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/jid.2011.476","article-title":"Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes","volume":"132","author":"Liebel","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"issue":"8","key":"10.1016\/j.det.2016.02.005_bib9","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1038\/jid.2010.95","article-title":"Impact of long-wavelength UVA and visible light on melanocompetent skin","volume":"130","author":"Mahmoud","year":"2010","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.02.005_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaad.2014.08.023","article-title":"Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial","volume":"72","author":"Boukari","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.02.005_bib11","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/phpp.12086","article-title":"Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial","volume":"30","author":"Castanedo-Cazares","year":"2014","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"4","key":"10.1016\/j.det.2016.02.005_bib12","first-page":"382","article-title":"New and emerging treatments for hyperpigmentation","volume":"13","author":"Alexis","year":"2014","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"9 Suppl","key":"10.1016\/j.det.2016.02.005_bib13","first-page":"s123","article-title":"Natural ingredients for darker skin types: growing options for hyperpigmentation","volume":"12","author":"Alexis","year":"2013","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.02.005_bib14","first-page":"52","article-title":"Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone","volume":"12","author":"Dahl","year":"2013","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.02.005_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jocd.12026","article-title":"Tranexamic acid: an important adjuvant in the treatment of melasma","volume":"12","author":"Tse","year":"2013","journal-title":"J\u00a0Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.02.005_bib16","first-page":"13","article-title":"Polypodium leucotomos as an adjunct treatment of pigmentary disorders","volume":"7","author":"Nestor","year":"2014","journal-title":"J\u00a0Clin Aesthet Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.02.005_bib17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/lsm.21156","article-title":"Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers","volume":"44","author":"Kauvar","year":"2012","journal-title":"Lasers Surg Med"},{"issue":"4","key":"10.1016\/j.det.2016.02.005_bib18","first-page":"315","article-title":"The treatment of melasma with topical creams alone, CO2 fractional ablative resurfacing alone, or a combination of the two: a comparative study","volume":"9","author":"Trelles","year":"2010","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.02.005_bib19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/ajd.12256","article-title":"Vitiligo treatment update","volume":"56","author":"Daniel","year":"2015","journal-title":"Australas J Dermatol"},{"issue":"4","key":"10.1016\/j.det.2016.02.005_bib20","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/exd.12103","article-title":"Vitiligo: interplay between oxidative stress and immune system","volume":"22","author":"Laddha","year":"2013","journal-title":"Exp Dermatol"},{"issue":"5","key":"10.1016\/j.det.2016.02.005_bib21","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1590\/abd1806-4841.20142717","article-title":"Vitiligo\u2013Part 2\u2013classification, histopathology and treatment","volume":"89","author":"Faria","year":"2014","journal-title":"An Bras Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.02.005_bib22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/bjd.13432","article-title":"Vitiligo Area Scoring Index and Vitiligo European Task Force assessment: reliable and responsive instruments to measure the degree of depigmentation in vitiligo","volume":"172","author":"Komen","year":"2015","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.02.005_bib23","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jaad.2012.01.038","article-title":"Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL)","volume":"69","author":"Lilly","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2016.02.005_bib24","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/bjd.13093","article-title":"Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument","volume":"171","author":"Gupta","year":"2014","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.02.005_bib25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus","volume":"168","author":"Taieb","year":"2013","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.det.2016.02.005_bib26","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.det.2007.04.008","article-title":"A\u00a0rational approach to the treatment of vitiligo and other hypomelanoses","volume":"25","author":"Hercogova","year":"2007","journal-title":"Dermatol Clin"},{"issue":"Suppl 1","key":"10.1016\/j.det.2016.02.005_bib27","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1529-8019.2008.00198.x","article-title":"Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects","volume":"21","author":"Lotti","year":"2008","journal-title":"Dermatol Ther"},{"issue":"5","key":"10.1016\/j.det.2016.02.005_bib28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4103\/0019-5154.139892","article-title":"Efficacy of targeted narrowband ultraviolet B therapy in vitiligo","volume":"59","author":"Majid","year":"2014","journal-title":"Indian J Dermatol"},{"issue":"10","key":"10.1016\/j.det.2016.02.005_bib29","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1097\/00042728-200510000-00003","article-title":"Surgical approaches for stable vitiligo","volume":"31","author":"Falabella","year":"2005","journal-title":"Dermatol Surg"},{"issue":"Suppl 3","key":"10.1016\/j.det.2016.02.005_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/bjd.12532","article-title":"Surgical interventions for vitiligo: an evidence-based review","volume":"169","author":"Mulekar","year":"2013","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2016.02.005_bib31","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/dth.12143","article-title":"Vitiligo nonsurgical treatment: a review of latest treatment researches","volume":"27","author":"Zhang","year":"2014","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.det.2016.02.005_bib32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/0378-6323.125479","article-title":"Randomized controlled study to evaluate the effectiveness of dexamethasone oral minipulse therapy versus oral minocycline in patients with active vitiligo vulgaris","volume":"80","author":"Singh","year":"2014","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"10.1016\/j.det.2016.02.005_bib33","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003263.pub5","article-title":"Interventions for vitiligo","author":"Whitton","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.det.2016.02.005_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.5070\/D338T939B8","article-title":"Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir","volume":"11","author":"Dogra","year":"2005","journal-title":"Dermatol Online J"},{"issue":"10","key":"10.1016\/j.det.2016.02.005_bib35","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1001\/jamadermatol.2015.1520","article-title":"Tofacitinib citrate for the treatment of vitiligo: a pathogenesis-directed therapy","volume":"151","author":"Craiglow","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.02.005_bib36","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1001\/jamadermatol.2014.1875","article-title":"Afamelanotide and narrowband UV-B phototherapy for the treatment of vitiligo: a randomized multicenter trial","volume":"151","author":"Lim","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.det.2016.02.005_bib37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/exd.12344","article-title":"Beyond vitiligo guidelines: combined stratified\/personalized approaches for the vitiligo patient","volume":"23","author":"Anbar","year":"2014","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2016.02.005_bib38","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0974-2077.155072","article-title":"Complications of tattoos and tattoo removal: stop and think before you ink","volume":"8","author":"Khunger","year":"2015","journal-title":"J\u00a0Cutan Aesthet Surg"},{"issue":"2","key":"10.1016\/j.det.2016.02.005_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1529-8019.2008.00178.x","article-title":"Vitiligo: new and emerging treatments","volume":"21","author":"Lotti","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.det.2016.02.005_bib40","series-title":"Fitzpatrick's color atlas and synopsis of clinical dermatology","first-page":"284","article-title":"Pigmentary disorders","author":"Wolff","year":"2013"},{"key":"10.1016\/j.det.2016.02.005_bib41","series-title":"Dermatology","first-page":"1049","article-title":"Disorders of hyperpigmentation","author":"Chang","year":"2012"},{"key":"10.1016\/j.det.2016.02.005_bib42","series-title":"Treatment of skin disease: comprehensive therapeutic strategies","first-page":"447","article-title":"Melasma","author":"Ogden","year":"2014"},{"key":"10.1016\/j.det.2016.02.005_bib43","series-title":"Andrews' diseases of the skin clinical dermatology","first-page":"847","article-title":"Disturbances of pigmentation","author":"Barral","year":"2011"},{"key":"10.1016\/j.det.2016.02.005_bib44","series-title":"The 2014\/2015 Derm in-review study guide","year":"2014"},{"key":"10.1016\/j.det.2016.02.005_bib45","series-title":"Annual meeting program book.","author":"Harris","year":"2015"},{"key":"10.1016\/j.det.2016.02.005_bib46","series-title":"Dermatology","first-page":"1023","article-title":"Vitiligo and other disorders of hypopigmentation","author":"Ortonne","year":"2012"},{"key":"10.1016\/j.det.2016.02.005_bib47","series-title":"Treatment of skin disease: comprehensive therapeutic strategies","first-page":"794","year":"2014"},{"issue":"4","key":"10.1016\/j.det.2016.02.005_bib48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaad.2008.06.024","article-title":"Skin of color education in dermatology residency programs: does residency training reflect the changing demographics of the United States?","volume":"59","author":"Nijhawan","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2016.02.005_bib49","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jaad.2014.12.026","article-title":"Randomized, parallel group trial comparing home-based phototherapy with institution-based 308 excimer lamp for the treatment of focal vitiligo vulgaris","volume":"72","author":"Tien Guan","year":"2015","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2016.02.005_bib50","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1365-2133.2010.09678.x","article-title":"Home vs. outpatient narrowband ultraviolet B therapy for the treatment of nonsegmental vitiligo: a retrospective questionnaire study","volume":"162","author":"Wind","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2016.02.005_bib51","unstructured":"Anderson KL, Huang KE, Huang WW, et\u00a0al. Dermatology resident training and comfort in prescribing in-office and home phototherapy. Paper Presented at 24th Annual Meeting of The Photomedicine Society. March 19, San Francisco, CA, 2015."},{"issue":"2","key":"10.1016\/j.det.2016.02.005_bib52","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jaad.2013.09.048","article-title":"The use of botanically derived agents for hyperpigmentation: a systematic review","volume":"70","author":"Fisk","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6 Suppl","key":"10.1016\/j.det.2016.02.005_bib53","first-page":"S72","article-title":"Innovations in natural ingredients and their use in skin care","volume":"9","author":"Fowler","year":"2010","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.det.2016.02.005_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10565-009-9121-2","article-title":"Modulation of antioxidant defense by Alpinia galanga and Curcuma aromatica extracts correlates with their inhibition of UVA-induced melanogenesis","volume":"26","author":"Panich","year":"2010","journal-title":"Cell Biol Toxicol"},{"issue":"2","key":"10.1016\/j.det.2016.02.005_bib55","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sder.2012.03.001","article-title":"New horizons in treating disorders of hyperpigmentation in skin of color","volume":"31","author":"Konda","year":"2012","journal-title":"Semin Cutan Med Surg"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351630016X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386351630016X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T08:35:16Z","timestamp":1656750916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386351630016X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":55,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S073386351630016X"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2016.02.005","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Practice and Educational Gaps in Abnormal Pigmentation","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}